Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label chronic lymphocytic leukemia (CLL). Show all posts
Showing posts with label chronic lymphocytic leukemia (CLL). Show all posts
Wednesday, January 27, 2016

Ibrutinib more effective than traditional chemotherapy in older untreated patients with CLL

›
In continuation of my update on  ibrutinib A multi-center, international, randomized, Phase III study of older untreated patients with...
Thursday, September 24, 2015

Ibrutinib (IMBRUVICA) improves survival in treatment-naïve patients with chronic lymphocytic leukemia

›
In continuation of my update on Ibrutinib Pharmacyclics LLC, an AbbVie company, announced that ibrutinib (IMBRUVICA®) improved p...
Wednesday, October 16, 2013

Phase 3 study of idelalisibin reports positive results in CLL patients

›
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its Phase 3 study (Study 116) evaluating idelalisib in previously-treated chronic...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.